logo
A new era in cancer care: The Bay Area's role in ending cancer for all

A new era in cancer care: The Bay Area's role in ending cancer for all

Across the Bay Area, momentum is building around a shared vision: ending cancer as we know it. The American Cancer Society (ACS) is privileged to work alongside forward-thinking communities from San Francisco to Silicon Valley to transform this vision into reality. With the landmark 14th annual San Francisco Discovery Gala approaching and unprecedented engagement from local innovation leaders, the opportunity for meaningful collaboration has never been more promising.
Cancer doesn't wait. Neither can we.
A legacy of Bay Area innovation and impact
Since 2011, the San Francisco Discovery Gala has channeled the Bay Area's entrepreneurial spirit into nearly $19 million to support breakthrough research, essential patient services, and effective advocacy. In 2023, it earned recognition as the American Cancer Society's Event of the Year — a testament to the Bay Area's distinctive ability to drive transformative change.
This signature event exemplifies what's possible when the region's visionary business leaders and passionate advocates unite for a common purpose. Distinguished past event chairs and sponsors represent many of the Bay Area's most influential employers, whose strategic partnerships continue to fuel ACS's life-saving work both locally and nationally.
Our mission: Measurable results
ACS stands as the largest private nonprofit funder of cancer research in the United States, with strategic investments exceeding $3.1 billion since 1991. This commitment has helped drive a remarkable 34% reduction in cancer mortality rates and prevented 4.5 million cancer deaths between 1991 and 2021. In 2024 alone, our mission positively impacted over 140.5 million lives through patient support, advocacy, and education.*
More than 80 cents of every dollar donated directly supports programs that empower people to prevent, detect, treat, and survive cancer. ACS benefits from the expertise of over 1 million volunteers in communities across the U.S., Puerto Rico, and Guam. Their invaluable contributions in 2024 represented more than $522 million in wage replacement value.*
expand
Cory Goodale
Prevention and detection: Progress and opportunity
The Cancer Prevention and Early Detection Facts & Figures 2025–2026 report reveals important gains while highlighting critical opportunities. Breast and colorectal cancer screening rates have successfully rebounded post-pandemic, and smoking rates continue their encouraging decline.
However, cervical cancer screening remains below optimal levels, and HPV vaccination rates have plateaued. Meanwhile, excess body weight, physical inactivity, and alcohol consumption present persistent public health challenges. ACS remains dedicated to expanding access to prevention and early detection tools, with particular focus on historically underserved populations.
"We're witnessing meaningful progress," notes Priti Bandi, Ph.D., ACS scientific director, "but now is precisely the time for Bay Area leaders to double down — especially on HPV and cervical cancer prevention."
California's strategic imperative
California faces one of the nation's most significant cancer challenges: projections indicate over 199,000 new diagnoses in 2025, with an estimated 60,000 cancer-related deaths.* These sobering numbers underscore the urgent need for continued investment and Bay Area leadership in the fight against cancer.
Bay Area innovation, national impact
Proceeds from the San Francisco Discovery Gala strengthen ACS's robust $400 million research portfolio, including more than 600 active grants nationwide — many based within premier Bay Area research institutions.* ACS-funded researchers are pioneering breakthroughs in treatment, early detection, and survivorship that will fundamentally reshape cancer care for everyone.
Our comprehensive services reached 75% of U.S. ZIP codes in 2024, providing critical transportation, lodging, and personalized support.* Our advocacy network extends across every state and territory, ensuring policy solutions that remove barriers to care and strengthen protections for everyone affected by cancer.
expand
Cory Goodale
Strategic partnership opportunities
ACS cultivates high-impact collaborations with health systems, nonprofits, and corporate leaders to expand access to cancer care and education. These strategic partnerships are central to our work advancing health equity, prevention, and workforce engagement.
In 2024 alone, we responded to more than 26,000 cancer information helpline calls in California, provided over 31,000 transportation services, delivered over 2,500 nights of free lodging, and facilitated direct navigation to care for thousands of residents.*
Young leaders addressing urgent trends
Cancer rates are increasing among adults under 50, a trend particularly relevant to Bay Area's young professional demographic. According to Cancer Facts & Figures 2025, cancers, including breast and colorectal, are rising among younger adults. This emerging challenge highlights the importance of initiatives like Fork Cancer Bay Area, led by the Associate Board of Ambassadors. This dynamic network of young professionals brings fresh perspective and long-term commitment to our mission, providing Bay Area companies with engagement opportunities for their emerging leaders.
Join Bay Area leaders in the fight
We invite Bay Area executives to distinguish themselves by joining the exclusive CEOs Against Cancer Bay Area Chapter. This influential network of senior leaders is advancing workplace wellness and community health through direct partnership with ACS. Members commit to building a best-in-class health culture while driving toward specific screening and prevention goals that benefit both their organizations and communities.
Membership includes:
Two annual high-level chapter meetings with fellow Bay Area executives
An appointed executive liaison to seamlessly integrate wellness initiatives enterprise-wide
Turnkey engagement toolkits and communications support to maximize impact
Access to exclusive networking and community events with the region's most influential leaders
With 83% of employers listing cancer among their top three health care cost drivers — and 74% of patients missing work, often four weeks or more — a healthier workforce isn't just a mission priority.* It's a compelling business imperative for Bay Area companies focused on talent retention and productivity.
Lead the way forward
The 2025 San Francisco Discovery Gala, taking place Sept. 27 at Chase Center, represents more than a premier social event — it's the cornerstone of a year-round movement. Strategic sponsorship connects your brand to measurable impact-driven outcomes and aligns your business with one of the most trusted and influential cancer-fighting organizations in the world.
Together, the Bay Area's most innovative companies and visionary leaders can shape a future where fewer lives are lost and every person has the opportunity to live a longer, healthier life.
Explore our comprehensive corporate partnership opportunities at cancer.org/becomeapartner or contact Leslie Irwin at leslie.irwin@cancer.org to discuss a customized engagement strategy.
To secure your place among Bay Area leaders at the San Francisco Discovery Gala, visit sfdiscoverygala.org or reach out to Leah Malfatti at leah.malfatti@cancer.org.
*According to American Cancer Society

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

2025 Cattle Baron's Ball raises money for cancer research in Tyler
2025 Cattle Baron's Ball raises money for cancer research in Tyler

Yahoo

time14 hours ago

  • Yahoo

2025 Cattle Baron's Ball raises money for cancer research in Tyler

TYLER, Texas (KETK) – The annual Cattle Baron's Ball was held at the Texas Rose Horse Park on Saturday as a way to benefit the American Cancer Society's work to end cancer. UT Tyler gets $441K grant to develop cancer-targeting nanotechnology The 'toe-tapping, knee-slapping' event featured food, drinks, dancing, an auction and raffle tickets, all supporting the American Cancer Society. 'The American Cancer Society is working to end cancer as we know it, for everyone. We are the largest private, not-for-profit funder of cancer research in the United States, investing more than $4 billion since 1946,' the American Cancer Society said. 'Thanks in part to our contributions, more than 1.5 million lives have been saved in the US in the past two decades. Now, that is a reason to celebrate!' According to the American Cancer Society's website, this year's mission with the Cattle Baron's Ball is to raise money for breast cancer research and to help provide access to cancer care across Texas by providing grants to cover transportation and lodging costs in Texas health systems. To learn more, visit the Cattle Baron's Ball online. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

American Cancer Society raises $400,000 with Walk & Roll event
American Cancer Society raises $400,000 with Walk & Roll event

Yahoo

time14 hours ago

  • Yahoo

American Cancer Society raises $400,000 with Walk & Roll event

CHICAGO – It was time to walk and roll Saturday morning! In Grant Park, 1,500 people worked up a sweat to raise money for the American Cancer Society in its 54th year. 'Walk and Roll' is the longest-running cancer fundraiser in Illinois. Participants had their choice of biking, skating, running or walking. Exercise may stop colon cancer from returning — and more 'We see people along the lakefront every day walking, running, biking, skating, so why not raise money for cancer research for that? We love to have survivors and caregivers out here. They're definitely the faces of what we do every day,' Jody Phillips of the American Cancer Society said. Cancer survivors include WGN-TV reporter Mike Lowe as well as motivational speaker and author Randi Moxi. 'I was diagnosed with colorectal cancer just about a year ago, and after a year of radiation and chemo therapy and treatment, I'm standing here today with the cancer undetectable,' Lowe said. Read more: Latest Chicago news and headlines 'It is overwhelming. It's beautiful. It's wonderful, and I think together we're going to make a huge difference and eventually get to an end of this nonsense,' Moxi added. The $400,000 raised during the event alone helps pay for research and patient care programs. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

How AI Is Helping Cancer Patients: Saving Lives And Money
How AI Is Helping Cancer Patients: Saving Lives And Money

Forbes

time2 days ago

  • Forbes

How AI Is Helping Cancer Patients: Saving Lives And Money

Medical technology concept. Medical doctor. getty Cancer treatment is costly. The average cost of cancer care in the U.S. is around $150,000 per patient—more than four times the cost of treatment for other common health conditions, according to AARP. The American Cancer Society projected that In 2025, more than 2 million people in the U.S. are expected to be diagnosed with cancer, with over 618,000 deaths projected. With these high costs, artificial intelligence (AI) is offering new solutions that are not only saving lives but also making cancer care more affordable. Early detection is one of the most effective ways to reduce cancer treatment costs. When cancer is caught in its earliest stages, treatments tend to be less aggressive and more affordable. At The Christ Hospital, AI has significantly improved lung cancer detection. 'Nearly 70% of lung cancer cases are now found at stage I or II, well above the national average of 46%,' said Seth Howard, executive vice president of research and development at Epic. 'In just six months, over 60 patients started treatment earlier, significantly improving their chances of survival.' By diagnosing cancer earlier, AI allows doctors to offer more cost-effective treatment options, which helps lower the financial burden on both patients and healthcare systems. ArteraAI is another example of how AI is transforming cancer care. Their AI technology is helping doctors determine which cancer treatments are best for their patients, preventing unnecessary therapies. 'AI is the most transformative tech we've had in a long time,' said Andre, founder of Artera. 'The impact AI has had on the healthcare system is as powerful as computers have had on the healthcare system. With the ArteraAI Prostate Test, we can personalize treatments, reducing unnecessary costs while improving outcomes.' The ArteraAI Prostate Test is fully reimbursed by Medicare under its established payment rate, meaning no out-of-pocket costs for eligible Medicare patients. This makes prostate cancer care more affordable and reduces financial strain during treatment. Surgery is often a key part of cancer treatment. Proprio, a company that has developed AI-powered surgical technology, provides surgeons with real-time data during operations, reducing the need for traditional imaging like CT scans and X-rays. This technology allows for faster surgeries, less strain on hospital staff, and quicker recovery times, which ultimately lowers the cost of care for patients. Another breakthrough demonstrating AI's transformative potential in cancer care is AION Biosystems' TempShield device. A recent study showed that TempShield, an AI-powered wearable thermometer for oncology patients, can reduce mortality rates by an astonishing 90% among cancer patients undergoing chemotherapy and inpatient hospital stays by 79%. This innovation addresses a crucial, yet often overlooked, fact: more than 50% of cancer deaths are preventable because they result from infections like pneumonia rather than cancer itself. If you spot a temperature spike (and hence an infection) early and treat it, you save lives. TempShield's continuous temperature monitoring provides clinicians with alerts up to 72 hours before symptoms of infection appear, enabling earlier intervention. 'The real danger in cancer care isn't just the disease—it's the complications we miss,' said Sam Barend, CEO of AION Biosystems. 'TempShield is a game-changer: small, simple, and affordable, and it's helping save lives by catching infections before symptoms appear—just like the blood glucose monitor did for diabetes.' AI is revolutionizing cancer care, not only improving outcomes but also making treatment more affordable. Early detection, personalized treatment, and more efficient surgeries all contribute to lowering the financial burden on patients while providing better care. With innovations like the ArteraAI Prostate Test and TempShield, AI is making cancer care smarter, more accessible, and more cost-effective for patients across the globe. As AI technologies continue to evolve, they will undoubtedly play an even greater role in both saving lives and reducing the financial strain of cancer treatment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store